Biocause Pharma(SZ:000627) Shen Zhen Shang Bao·2025-10-17 04:36Core Points - Guohua Life Insurance Co., Ltd. Shanghai Branch was fined 340,000 yuan due to false expense usage [1][2] - Zhong Heqing, the former director of Guohua Life Insurance Shanghai Branch, received a warning and was fined 50,000 yuan [1][2] Company Overview - Guohua Life Insurance was established in November 2007, headquartered in Shanghai, with a registered capital of 4.846 billion yuan [2][3] - The company is a nationwide, joint-stock professional life insurance company approved by the former China Insurance Regulatory Commission [2][3] Shareholder Structure - The company has seven shareholders, with Tianmao Group being the largest, holding 51% of the shares [3] - Other shareholders include Ningbo Kaiyihe (15.05%), Ningbo Boyonglun (13.91%), Ningbo Hanshengxin (9.47%), Hubei Hongtai (9.22%), Wuhan Urban Construction Group (1.14%), and Wuhan Jiang'an State-owned Assets (0.23%) [3] - Liu Yiqian is the actual controller of Guohua Life Insurance [3] Financial Performance - From 2014 to 2022, Guohua Life Insurance reported net profits of 1.427 billion yuan, 1.649 billion yuan, 1.653 billion yuan, 2.733 billion yuan, 2.055 billion yuan, 2.216 billion yuan, 1.111 billion yuan, 849 million yuan, and 484 million yuan respectively [3] - In 2023, the company experienced a significant downturn, reporting a net loss of 1.155 billion yuan [3] - As of the end of 2023, the company had an undistributed profit of 7.899 billion yuan on its consolidated balance sheet [3]